Consumers purchase roughly 40 million bottles of over-the-counter (OTC) anti-allergic eye drops each year and another 4 million prescription drops, according to a 2003 study. These statistics are unfortunate because we have vastly superior prescription medications to help these patients better manage allergic conjunctivitis, one of the most frequently occurring ocular conditions that we see. This also means that allergy is a nice niche for us to fill so we can expand into our therapeutic privileges. In my experience, roughly 85% of patients with systemic allergies suffer from some stage of ocular manifestations, so it’s important for us to stay up-to-date in this area. The following discussion should help.

Read more